Baxter International Inc. (LON:0QK8)
London · Delayed Price · Currency is GBP · Price in USD 19.42
-2.86 (-12.82%)
Feb 12, 2026, 4:59 PM GMT
Baxter International Market Cap
Baxter International has a market cap or net worth of 8.39 billion as of February 12, 2026. Its market cap has decreased by -37.48% in one year.
Market Cap
8.39B
Enterprise Value
14.22B
Revenue
8.35B
Ranking
n/a
PE Ratio
n/a
Stock Price
19.42
Market Cap Chart
Since January 2, 1968, Baxter International's market cap has increased from 611.84M to 8.39B, an increase of 1,271.36%. That is a compound annual growth rate of 4.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 8.39B | 14.95% |
| Dec 31, 2025 | 7.30B | -38.63% |
| Dec 31, 2024 | 11.89B | -22.76% |
| Dec 29, 2023 | 15.40B | -27.80% |
| Dec 30, 2022 | 21.33B | -32.81% |
| Dec 31, 2021 | 31.74B | 5.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.40B |
| GSK plc | 86.64B |
| Haleon | 34.95B |
| Smith & Nephew | 10.82B |
| Convatec Group | 4.41B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 2.04B |
| HUTCHMED (China) | 1.82B |